Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 7, 2023
The effectiveness and safety of Chinese Patent Medicines based on syndrome differentiation in patients following percutaneous coronary intervention due to acute coronary syndrome (CPM trial): A nationwide Cohort StudyRuina Bai, Qiaoning Yang, Ruixi Xi, et al.
International Journal of Biological Sciences|September 23, 2024
Dissection of Targeting Molecular Mechanisms of Celastrol-induced Nephrotoxicity <i>via</i> A Combined Deconvolution Strategy of Chemoproteomics and MetabolomicsXueying Liu, Qian Zhang, Peili Wang, et al.
Kidney International|December 24, 2010
Renalase deficiency aggravates ischemic myocardial damageYanling Wu, Jianchao Xu, Heino Velazquez, et al.
RSC Medicinal Chemistry|March 19, 2026
Discovery of <b>GBA-16-24</b> as a highly potent, selective ATR inhibitor for the treatment of FLT3-mutated acute myeloid leukemiaPing Li, Haiyan Ren, Xinyan Lan, et al.
Frontiers in Cardiovascular Medicine|October 9, 2024
Efficacy of Danlou tablets in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a multicenter prospective cohort studyYajie Cai, Qiaoning Yang, Ruixi Xi, et al.
Cancer Letters|January 6, 2022
An orally available small molecule BCL6 inhibitor effectively suppresses diffuse large B cell lymphoma cells growth in vitro and in vivoYajing Xing, Weikai Guo, Min Wu, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 4, 2024
Engineering Semiconducting Polymeric Nanoagonists Potentiate cGAS-STING Pathway Activation and Elicit Long Term Memory Against Recurrence in Breast CancerHaitao Yuan, Chong Qiu, Xiaoxian Wang, et al.
International Journal of Biological Sciences|June 16, 2025
PARP inhibitor augments anti-tumor efficacy of DNMT inhibitor by inducing senescence in cholangiocarcinomaPeili Wang, Rong Xiao, Jianfeng Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 9, 2021
Inhibition of the PLK1-Coupled Cell Cycle Machinery Overcomes Resistance to Oxaliplatin in Colorectal CancerZhaoliang Yu, Peng Deng, Yufeng Chen, et al.
Molecular Cancer|May 20, 2023
EZH2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancerJianfeng Chen, Jing Han Hong, Yulin Huang, et al.
Pageof 11